Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Lancet. Microbe|May 11, 2022
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in RwandaJean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, et al.
BMJ Open|July 25, 2024
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trialJihad Snobre, Joel Gasana, Jean Claude Semuto Ngabonziza, et al.
Journal of the International AIDS Society|July 11, 2019
Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration studyAminata Mboup, Luc Béhanzin, Fernand A Guédou, et al.
Nature Communications|June 11, 2020
A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes regionJean Claude Semuto Ngabonziza, Chloé Loiseau, Michael Marceau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2020
Mathematical Model Impact Analysis of a Real-Life Pre-exposure Prophylaxis and Treatment-As-Prevention Study Among Female Sex Workers in Cotonou, BeninLily Geidelberg, Kate M Mitchell, Michel Alary, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|February 11, 2022
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter centuryJean Claude S Ngabonziza, Leen Rigouts, Gabriela Torrea, et al.
Microbial Genomics|February 8, 2021
Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary historyMireia Coscolla, Sebastien Gagneux, Fabrizio Menardo, et al.
JAMA Network Open|July 9, 2026
Antimicrobial Resistance Trends in Urinary Tract Infections in 6 African CountriesLala Fanomezantsoa Rafetrarivony, Félix Cheysson, Dissou Affolabi, et al.
ERJ Open Research|March 11, 2026
Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan AfricaFaridath Massou, Bassirou Diarra, Awa Ba Diallo, et al.
Nature Communications|May 19, 2021
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimensNicholas D Walter, Sarah E M Born, Gregory T Robertson, et al.
Pageof 9